A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Clinical trial NCT06213259 · COMPLETED

Trial details

NCT number: NCT06213259
Sponsor: Shanghai Kanda Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2024-01-06
Primary completion: 2025-01-10
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.